These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1247769)

  • 21. A prospective randomized controlled trial of oral ciprofloxacin in acute ulcerative colitis.
    Mantzaris GJ; Archavlis E; Christoforidis P; Kourtessas D; Amberiadis P; Florakis N; Petraki K; Spiliadi C; Triantafyllou G
    Am J Gastroenterol; 1997 Mar; 92(3):454-6. PubMed ID: 9068468
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The treatment of ulcerous colitis with retention enemas of prednisolone and phthalysulfathiazole (Preliminary communication)].
    MITCHELL HG
    Prensa Med Argent; 1959 Jun; 46():1577-9. PubMed ID: 14422967
    [No Abstract]   [Full Text] [Related]  

  • 23. 5-Aminosalicylic acid enemas in refractory distal ulcerative colitis: a randomized, controlled trial.
    Friedman LS; Richter JM; Kirkham SE; DeMonaco HJ; May RJ
    Am J Gastroenterol; 1986 Jun; 81(6):412-8. PubMed ID: 3518408
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intraarterial prednisolone infusion therapy in ulcerative colitis.
    Momoshima S; Kohda E; Hiramatsu K; Asakura H
    AJR Am J Roentgenol; 1985 Nov; 145(5):1057-60. PubMed ID: 3876736
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intensive intravenous regimen for severe attacks of ulcerative colitis.
    Truelove SC; Jewell DP
    Lancet; 1974 Jun; 1(7866):1067-70. PubMed ID: 4135487
    [No Abstract]   [Full Text] [Related]  

  • 26. Bioavailability and therapeutic activity of alicaforsen (ISIS 2302) administered as a rectal retention enema to subjects with active ulcerative colitis.
    Miner PB; Geary RS; Matson J; Chuang E; Xia S; Baker BF; Wedel MK
    Aliment Pharmacol Ther; 2006 May; 23(10):1427-34. PubMed ID: 16669957
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Complement activation capacity in plasma before and during high-dose prednisolone treatment and tapering in exacerbations of Crohn's disease and ulcerative colitis.
    Zimmermann-Nielsen E; Grønbaek H; Dahlerup JF; Baatrup G; Thorlacius-Ussing O
    BMC Gastroenterol; 2005 Sep; 5():31. PubMed ID: 16179087
    [TBL] [Abstract][Full Text] [Related]  

  • 28. URINARY EXCRETION OF PREDNISOLONE AFTER INTRARECTAL THERAPY IN ULCERATIVE COLITIS.
    WOOD WA; WALTERS G; FLAVELLMATTS SG
    Br Med J; 1964 Oct; 2(5416):1045-6. PubMed ID: 14191165
    [No Abstract]   [Full Text] [Related]  

  • 29. Plasma prednisolone levels during intravenous therapy in acute colitis.
    Berghouse LM; Elliott PR; Lennard-Jones JE; English J; Marks V
    Gut; 1982 Nov; 23(11):980-83. PubMed ID: 7129207
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 5-Aminosalicylic acid in patients with ulcerative colitis in remission: plasma levels after administration of a new rectal enema.
    Gionchetti P; Belluzzi A; Campieri M; Torresan F; Tabanelli GM; Brignola C; Miglioli M; Barbara L
    Methods Find Exp Clin Pharmacol; 1988 Oct; 10(10):667-9. PubMed ID: 3236941
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of oxygen-derived free radical scavengers in the management of recurrent attacks of ulcerative colitis: a new approach.
    Salim AS
    J Lab Clin Med; 1992 Jun; 119(6):710-7. PubMed ID: 1350610
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 5-Aminosalicylic acid enemas in patients with active ulcerative colitis. Influence of acidity on the kinetic pattern.
    Bondesen S; Nielsen OH; Jacobsen O; Rasmussen SN; Hansen SH; Halskov S; Binder V; Hvidberg EF
    Scand J Gastroenterol; 1984 Jul; 19(5):677-82. PubMed ID: 6382570
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of sulphydryl-containing agents in the management of recurrent attacks of ulcerative colitis. A new approach.
    Salim AS
    Pharmacology; 1992; 45(6):307-18. PubMed ID: 1362613
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 5-Aminosalicylic acid enemas in refractory distal ulcerative colitis: long-term results.
    Guarino J; Chatzinoff M; Berk T; Friedman LS
    Am J Gastroenterol; 1987 Aug; 82(8):732-7. PubMed ID: 3496786
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Experiences with immunosuppressive therapy in childhood ulcerative colitis.
    Schäfer KH; Bläker F
    Z Kinderheilkd; 1971; 110(4):317-23. PubMed ID: 5567009
    [No Abstract]   [Full Text] [Related]  

  • 36. Topical 5-aminosalicylic acid versus prednisolone in ulcerative proctosigmoiditis. A randomized, double-blind multicenter trial. Danish 5-ASA Group.
    Dig Dis Sci; 1987 Jun; 32(6):598-602. PubMed ID: 2882966
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative study of enema retention and preference in ulcerative colitis.
    Ingram JR; Rhodes J; Evans BK; Newcombe RG; Thomas GA
    Postgrad Med J; 2005 Sep; 81(959):594-8. PubMed ID: 16143691
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nicotine enemas for treatment of ulcerative colitis: a study of the pharmacokinetics and adverse events associated with three doses of nicotine.
    Ingram JR; Routledge P; Rhodes J; Marshall RW; Buss DC; Evans BK; Feyerabend C; Thomas GA
    Aliment Pharmacol Ther; 2004 Oct; 20(8):859-65. PubMed ID: 15479357
    [TBL] [Abstract][Full Text] [Related]  

  • 39. On the absorption of prednisone and prednisolone disodium phosphate after rectal administration.
    Halvorsen S; Myren J; Aakvaag A
    Scand J Gastroenterol; 1969; 4(7):582-4. PubMed ID: 5374927
    [No Abstract]   [Full Text] [Related]  

  • 40. Intrarectal treatment of 100 cases of ulcerative colitis with prednisolone-21-phosphate enemata.
    MATTS SG
    Br Med J; 1961 Jan; 1(5220):165-8. PubMed ID: 13768326
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.